The Pan-Mass Challenge (PMC), an athletic fundraiser in the US, has donated $72m to the Dana-Farber Cancer Institute.

The donation is being claimed to be PMC’s largest ever for cancer research and treatment.

This brings PMC’s total support to Dana-Farber through the Jimmy Fund to $972m since its inception in 1980.

PMC aims to surpass the $1bn mark for the Institute by 2024, continuing its support for cancer research and treatment.

The five-year relative cancer survival rate was 50% in 1980 when PMC was launched. Currently, the rate has increased to over 65%.

Other achievements include funding for blood tests for early detection of rare paediatric kidney cancer and recurrent HPV-driven oropharyngeal cancer.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The $72m gift was revealed at a celebratory event in Boston.

PMC remains the primary contributor to Dana-Farber, contributing 62% of the Jimmy Fund’s annual revenue.

As a federally designated Comprehensive Cancer Center and an affiliate of Harvard Medical School, Dana-Farber delivers advanced cancer treatments for adults through the Dana-Farber Brigham Cancer Center and for children through the Dana-Farber/Boston Children’s Cancer and Blood Disorders Center.

It has carried out more than 1,100 clinical trials.

PMC founder and executive director Billy Starr said: “Our riders continue to expand the very definition of what a bike-a-thon, and a bicycle, was really meant to do! Their support of the PMC and Dana-Farber is unwavering.

“The impact this year’s gift has is unparalleled and, as we head towards $1bn cumulatively raised, this is a proud moment to celebrate the progress that has been made in the fight against cancer thanks in large part to PMC fundraising efforts.”